Fig. 2From: Metastasis directed stereotactic radiotherapy in NSCLC patients progressing under targeted- or immunotherapy: efficacy and safety reporting from the ‘TOaSTT’ databaseFlow chart of systemic therapy switch following SRTBack to article page